trending Market Intelligence /marketintelligence/en/news-insights/trending/HSBq0cU-vGGrE9iV5G7B0g2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

OptiNose to raise $120M in upsized IPO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


OptiNose to raise $120M in upsized IPO

OptiNose Inc. will sell more common shares than planned and raise $120 million in its initial public offering.

The company will sell 7.5 million shares for $16 apiece. It had originally planned to sell 6,250,000 common shares in the IPO at between $15 and $17 apiece.

OptiNose granted underwriters an option to buy up to an additional 1,125,000 common shares.

The shares are expected to start trading Oct. 13 on the Nasdaq Global Select Market under the symbol OPTN.

The offering is expected to close Oct. 17.

Jefferies and Piper Jaffray are acting as the lead joint book-running managers of the offering. BMO Capital Markets and RBC Capital Markets are acting as joint book-running managers for the offering.